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Abstract
With single blastocyst transfer practice becoming more common in ART, there is a greater demand
for a convenient and reliable cryostorage of surplus blastocysts. Vitrification has emerged in the last
decade as an alternative promising substitute for slow freezing. Blastocysts represent a unique
challenge in cryostorage due to their size, multicellular structure and presence of blastocoele. The
continuous acquisition of experience and introduction of many different technological
developments has led to the improvement of vitrification as a technology and improved the results
of its application in blastocyst cryostorage. The current information concerning safety and efficacy
of the vitrification of blastocysts will be reviewed along with the variables that can impact the
outcome of the procedure.
Background
With the refinement of extended culture systems, it is
becoming more reliable to obtain blastocysts in vitro [1].
Due their high implantation rates, it is becoming a com-
mon practice to limit transfer to one or two blastocysts at
a time. Therefore, surplus blastocysts require an efficient
cryopreservation method [2,3]. Slow freezing was the
main method of cryopreservation [4], but vitrification is
now on the rise. Vitrification is the glass-like solidification
of a solution at a low temperature without ice crystal for-
mation, which is made possible by extreme elevation in
viscosity during freezing. This can be achieved by increas-
ing the freezing and warming rates and/or increasing the
concentration of the cryoprotectants [5]. Unlike slow
freezing, vitrification results in the total elimination of ice
crystal formation, both within the cells being vitrified and
outside the cells in the surrounding solution [6].
Although high concentrations of cryoprotectants can be
toxic, and the vitrified solution is prone to glass fractures,
these effects can be controlled by adjusting the vitrifica-
tion protocol and technique. With vitrification, the blast-
ocyst is combined with cryoprotectants that maximize
cytoplasmic viscosity while exerting a strong dehydrating
effect. Vitrification is more convenient and is possibly
superior because it avoids ice crystal formation. Over the
last decade, vitrification techniques have been standard-
ized, tested and improved via controlled experiments
designed to elucidate the optimal conditions under which
vitrification should be performed. This review will discuss
the most commonly used loading devices, vitrification
safety in terms of perinatal outcomes, and the factors that
can affect the success of human blastocyst vitrification.
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Human blastocysts vitrified using different 
loading devices
During vitrification, the blastocyst is placed in a loading
device surrounded by vitrification media. The device is
then placed into liquid nitrogen, where it is stored. There
are a variety of loading devices available today: the Cry-
oloop, Cryotop, Cryoptip, Cut Standard Straws, Cryo-
leaf™ and High Security Straws™. The Cryoloop is a nylon
loop, whereas the Cryotop is a plastic container. These are
considered open systems because the blastocysts come
into direct contact with the liquid nitrogen. Cryotips are
plastic straws with protective metal sleeves and is heat
sealed from both ends after loading, thus constituting a
closed system. The cut standard straw is a system that can
be used as an open method (by direct contact with liquid
nitrogen) or closed if placed inside a sealed standard straw
(straw within straw). The Cryo-leaf™ is a plastic carrier
open system, vitrifying the specimen by direct contact.
High security straws are plastic straws sealed after loading,
and are thus considered a closed system. Table 1 summa-
rizes the survival, implantation and pregnancy rates of
human blastocysts vitrified using different loading
devices.
In 1999, Lane et al [7] reported that human blastocysts vit-
rified by cryoloop had hatching rates similar to those of
fresh blastocysts. Mukaida et al [8,9] and Reed et al [10]
vitrified blastocysts using the Cryoloop, producing sur-
vival rates ranging from 63% to 100% and pregnancy rates
ranging from 31% to 37%. In 2001, Mukaida et al
reported the first successful delivery of three healthy new-
borns who had been conceived via blastocyst vitrification
using the Cryoloop [8].
In 2003, Osada et al [11] studied the vitrification of blast-
ocysts using the Cryotop™ and reported 99% survival rate
and 56% pregnancy rate, which was even higher than the
31% pregnancy rate in their fresh blastocyst transfer
group. Stehlik et al [12] and Liebermann and Tucker [13]
compared vitrification by Cryotop™ with conventional
slow freezing methods. Liebermann and Tucker [13] did
not find a statistically significant difference in survival and
pregnancy rates between blastocysts vitrified by the Cryo-
top™ and those cryopreserved by slow freezing. On the
other hand, Stehlik et al [12] reported that survival and
pregnancy rates of blastocysts vitrified by the Cryotop™
significantly exceeded the rates of blastocyst survival after
slow cryopreservation.
Despite the wide use and successful vitrification of human
and animal oocytes and embryos using open pulled
straws (OPS) [14,15], only modified OPS were used by
Cremades et al [16] and resulted in survival rate of 82% in
a small sample of 33 human blastocysts.
In 2005, Kuwayama et al [17] performed a study that val-
idated the use of the Cryotip™ for the first time, reporting
that the Cryotip™ produced results that were comparable
to those of the Cryotop™ carrier. The Cyrotip™ demon-
strated 93% blastocyst survival rate and 51% pregnancy
rate with no statistical difference when compared with the
rates of the Cryotop™ [18].
In 2005, Takahashi et al [19] reported the clinical out-
comes of a 4-year study on 1129 vitrified human blasto-
cysts using the cryoloop. This large sample size
demonstrated that the pregnancy rate and implantation
rates using vitrified blastocysts were comparable to those
associated with use of fresh blastocysts.
In a recent report by Liebermann et al [20], of 8,449 blas-
tocysts from 2,453 patients that were vitrified, 1398 vitri-
fied blastocysts were transferred with a survival rate of
96.3%, an implantation rate of 29.4%, and a clinical preg-
nancy rate per frozen embryo transfer of 42.9%.
Blastocysts can also be vitrified on an electronic micro-
scope (EM) copper grid. Cho et al [21] reported vitrifying
human blastocysts in this manner with a survival rate of
83% and a pregnancy rate of 34%.
Table 1: Comparison of survival, implantation and pregnancy rates according to loading device
Loading Device Sample Size Survival Rate Implantation Rate Pregnancy Rate
Mukaida et al, 2001[8] Cryoloop N = 60 63% -- 31%
Cho, 2002 et al [21] EM grid N = 21 83% -- 34%
Reed et al, 2002[10] Cryoloop N = 54 100% 15% --
Mukaida et al, 2003[9] Cryoloop N = 725 80% 20% 37%
Osada et al, 2003[11] Cryotop N = 580 99% -- 56%
Stehlik et al, 2005[12] Cryotop N = 41 100% -- 50%
Takahashi et al, 2005[19] Cryoloop N = 1129 86% 29% 44%
Kuwayama et al, 2005[18] Cryotip N = 5695 90% -- 53%
Liebermann et al, 2006[13] Cryotop N = 547 97% 31% 46%
Mukaida et al, 2008[29] Cryoloop N = 5412 92% 36% 49%Reproductive Biology and Endocrinology 2009, 7:99 http://www.rbej.com/content/7/1/99
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Obstetric and perinatal outcomes
Multiple pregnancy is the main source of obstetric and
perinatal morbidity associated with assisted reproduction.
The transfer of blastocysts allowed one or two blastocysts
to be transferred with high implantation potential, while
minimizing the risks of multiple pregnancies. Single blas-
tocyst transfer completely avoids dizigotic twin pregnancy
[1,22-25].
Vitrification has been in clinical use for more than 15
years. And while multiple studies have reported excellent
cryosurvival and pregnancy rates using vitrified oocytes or
embryos, there are still concerns regarding the overall
safety of vitrification and whether it can cause or lead to
chromosomal abnormalities, congenital malformation,
and/or developmental abnormalities in the offspring
[26,27]. As a result, no general recommendation in favor
of its regular clinical use has been issued.
Part of the problem is a lack of well-controlled clinical tri-
als. Noyes et al [28] reviewed a total of 58 reports (1986-
2008) on 900 cryopreserved oocytes looking for data on
congenital anomalies in 609 live born babies (308 from
slow-freezing, 289 from vitrification and 12 from both
methods). Twelve newborns (1.3%) had birth anomalies,
which is comparable to the number of congenital anoma-
lies that occur in naturally conceived infants. Analyzing
the obstetric and perinatal outcomes following transfer of
vitrified blastocysts would be even more challenging due
to the limited number of reports, though this number is
rapidly rising.
Takahashi et al [19] reported congenital birth defects of
1.4% using vitrified blastocysts which was similar to fresh
blastocysts. In a preliminary report on the effect of blasto-
cyst vitrification on perinatal outcomes, Mukaida et al
[29] analyzed 560 deliveries of 691 healthy babies follow-
ing the transfer of vitrified blastocysts. The congenital and
neonatal complication rate was 3%, which was compara-
ble to that in their fresh blastocysts transfer group (2.3%).
No perinatal abnormalities were reported in Lieber-
mann's report on 348 deliveries of 431 babies following
transfer of vitrified blastocysts [20].
These findings may provide preliminary reassurance on
the safety of blastocyst vitrification. A final verdict on the
actual effect of blastocyst vitrification on congenital and
perinatal outcomes may not be possible until large-scale
trials or further meta-analysis of rapidly accumulating
reports can be performed.
Factors that can affect the outcome
There are a number of variables that can determine the
outcomes of vitrification:
￿Pre-vitrification blastocyst selection
￿Post-thaw blastocyst selection
￿Assisted hatching (Figure 1)
￿Blastocoele collapse (assisted shrinkage) (Figure 1)
￿Media protocols
￿Freezing rate
￿Warming rate
￿Operator-dependent factors
￿Hydrostatic pressure
Pre-vitrification blastocyst selection
Selection focuses on the quality of the original embryo
and/or the time at which the blastocyst is vitrified.
Influence of early embryonic quality
The quality of an early embryo determines the quality of
the blastocyst, and therefore the outcome of the blastocyst
vitrification. In a study by Vanderzwalmen et al [30], vitri-
fied blastocysts that originated from a cohort of early
embryos with less than 30% fragmentation had survival,
implantation and ongoing pregnancy rates of 73%, 32%
and 19%, respectively. In contrast, when the blastocysts
came from embryos with 30-50% fragmentation and/or
unequally sized blastomeres, these rates decreased to
38%, 9% and 6%, respectively. These findings highlight
the importance of following the day-by-day development
of each embryo so that the outcome of blastocyst vitrifica-
tion and later transfer can be predicted.
Day 5 versus day 6 vitrification
Blastulation of human embryos usually occurs on day 5
after fertilization but may be delayed until day 6. The
transfer of fresh day-5 blastocysts seems to result in higher
pregnancy rates than the transfer of fresh day-6 blastocysts
[11,31,32]. However, the transfer of slowly cryopreserved
day-6 blastocysts results in comparable pregnancy rates to
the transfer of cryopreserved day-5 blastocysts [13,33].
This may be related to better endometrial synchrony in
the cryopreserved blastocyst transfer cycles; the endome-
trial receptivity window may be missed in day 6 fresh
transfer [34].
Table 2 summarizes the different studies that have com-
pared day-5 with day-6 blastocyst cryopreservation.
In different clinical studies, day-5 blastocysts were gener-
ally associated with better outcomes following cryopreser-Reproductive Biology and Endocrinology 2009, 7:99 http://www.rbej.com/content/7/1/99
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Different pre-vitrification interventions for blastocysts Figure 1
Different pre-vitrification interventions for blastocysts. A. Assisted hatching: An opening is created in the zona using 
laser pulse B. Needle blastocoele puncture: A needle is passed through the zona and blastocoele and retracted allowing the 
blastocelic fluid to freely leak. C. Laser blastocoele puncture: laser pulse creates an opening in the zona and a small defect in 
the trophectoderm causing the blastocoele to leak. D. Blastocoele aspiration: An injection needle is introduced into the blast-
ocoele and blastocoelic volume is sucked out. E. Micropipetting: Passing the blastocysts through a narrow pipette would crack 
the zona and compress the blastocoele to leak through the cracked zona.Reproductive Biology and Endocrinology 2009, 7:99 http://www.rbej.com/content/7/1/99
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vation by vitrification than day-6 blastocysts. Mukaida et
al and Veeck et al reported superior survival rates with
blastocysts vitrified on day 5 compared with those vitri-
fied on day 6 [9,35]. In a study with 41 vitrified blasto-
cysts, Stehlik et al [12] reported a pregnancy rate of 50%
using vitrified day-5 blastocysts, compared with a 33%
pregnancy rate using day-6 blastocysts. Liebermann and
Tucker [13] found that implantation and pregnancy rates
were significantly higher after the transfer of day-5 vitri-
fied blastocysts than after transfer with day-6 blastocysts.
However, they did not find a statistically significant differ-
ence in survival rates between the two groups. The results
of slow cryopreservation of day-5 versus day-6 blastocysts
were similar, although no statistical significance between
the two groups was reached.
We have recently shown that day-5 blastocysts have less
DNA damage than day-6 blastocysts, although the differ-
ence was not statistically significant due to a limited sam-
ple size [36].
The superior outcomes associated with vitrified day-5
blastocysts may be related to the fact that many of the day-
6 blastocysts were delayed in development, suggesting
that they were of inferior quality. In the case of expanded
good quality day 6 blastocysts, damage could still be
explained by an increase in number of blastomeres,
increase in their metabolic activity and an increase in blas-
tocoele expansion. Any of these factors could increase the
likelihood of inadequate vitrification, ice crystal forma-
tion, and cryodamage [36,37]. Therefore, embryos that
undergo blastulation on day 5 would better be vitrified on
day 5, while embryos delayed in development may be
allowed to develop to day 6 until vitrified. The rate of
development and the degree of expansion are more likely
to affect the outcome than the day of vitrification [13,36].
After all, transferred vitrified embryos will benefit from a
better endometrial synchrony, which may dampen nega-
tive effects from cryostorage [34].
Post-thaw blastocyst selection
Post-warming, viable blastocysts re-expand and are usu-
ally allowed four to six hours of incubation to regain their
vitality before being transferred. Re-expansion is the sign
of viability. An important predictor of the transfer of vitri-
fied-warmed blastocyst is the blastocyst re-expansion tim-
ing. The earlier the blastocyst expands, the better it is
expected to perform after transfer [38].
Assisted hatching
Pribenszky  et al [39] studied the survival of zona-free
mouse blastocysts. There was no difference in survival
after thawing between these blastocysts and fresh control
blastocysts. This experiment suggested that the intact zona
pellucida can potentially negatively impact blastocyst vit-
rification
In lieu of using zona-free blastocysts, which may not be
practical with human blastocysts, assisted hatching can be
performed prior to vitrification. With assisted hatching, a
small hole is created in the zona pellucida so that the blas-
tocyst can more easily escape or "hatch." It was primarily
thought to overcome the post-freezing zonal hardening
preventing spontaneous hatching and it proved effective
[30].
Assisted hatching has been shown to improve the out-
come of vitrification of blastocysts through another mech-
anism. Applying assisted hatching prior to blastocyst
vitrification allows better permeation of the cryoprotect-
ants and better blastocoele dehydration [36,40]. Zech et al
[40] found that vitrified warmed blastocysts that had
undergone assisted hatching had significantly better sur-
vival, implantation and pregnancy rates than blastocysts
with an intact zona. In concordance with Zech's findings,
we have demonstrated that assisted or spontaneous hatch-
ing both have a significantly positive impact on the post-
warming DNA integrity index of mice blastocysts post-
warming as compared with zona-intact blastocysts [36].
These two studies show that assisted hatching is a useful
and effective pre-vitrification intervention that can reduce
Table 2: Different studies comparing the slow preservation and/or vitrification of day 5 and day 6 blastocysts in terms of survival after 
warming, implantation and pregnancy rates
Slowly frozen Day 5 
Blastocysts
Slowly frozen Day 6 
Blastocysts
Vitrified Day 5 
Blastocysts
Vitrified Day 6 
Blastocysts
Mukaida et al. 2003[9] Survival 87% Survival 55%
Stehlik et al. 2005[12] Survival 83.1%
Pregnancy rate 16.7%
Survival 89.5%
Pregnancy rate 18.5%
Survival 100%
Pregnancy rate 50%
Survival 100%
Pregnancy rate 33%
Liebermann & Tucker 
2006[13]
Survival 91.4%
Implantation 29.6%
Pregnancy rate 42.8%
Survival 94.8%
Implantation 28.2%
Pregnancy rate 43.1%
Survival 95.9%
Implantation 33.4%
Pregnancy 48.7%
Survival 97.5%
Implantation 25.9%
Pregnancy 42.8%
Kader et al. 2008[36] DNA integrity index: 
94.76% ± 4.70
DNA integrity index: 
90.87% ± 6.16
DNA integrity index: 
84.36% ± 8.76
DNA integrity index: 
77.61% ± 16.65Reproductive Biology and Endocrinology 2009, 7:99 http://www.rbej.com/content/7/1/99
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DNA damage incurred during the vitrification process and
improve clinical outcome parameters.
Table 3 summarizes the results of studies assessing the
outcomes of pre-vitrification assisted hatching.
Blastocoele collapse (assisted shrinkage)
Much attention has been paid to the volume of the blast-
ocoele prior to vitrification and its effect on the overall
success of vitrification. A negative correlation between
blastocelic volume and outcome measures has been
attributed to an increased likelihood of intracellular ice
formation in an inadequately dehydrated blastocoele
[41,42]. Consequently, a process called assisted shrinkage
was developed to reduce blastocelic volume prior to vitri-
fication. Assisted shrinkage can be performed in a variety
of ways, including micro-needle puncture of the zona pel-
lucida [37,41,43], laser-pulse opening of the zona pelluc-
ida [41], repeated micropipetting of the blastocoele [44],
and microsuction of the blastocoelic contents [42,45]
Mukaida et al [41] reported significant improvements in
clinical outcome measures in blastocysts that had under-
gone assisted shrinkage as compared with a retrospective
vitrification control group. There were no statistical differ-
ences in survival, implantation and clinical pregnancy
rates between blastocysts that had undergone laser pulse
opening or micro-needle puncture [41]. Vanderzwalmen
et al and Son et al have also reported improved results
using micro-needle puncture of blastocysts prior to vitrifi-
cation [37,43].
Hiraoka et al, [44] mechanically collapsed blastocysts by
repeated micropipetting prior to vitrification. The investi-
gators reported 98% survival rate, 33% implantation rate,
and 50% pregnancy rate in a sample of 48 vitrified blast-
ocysts.
Chen et al [42] reported significant improvement in sur-
vival rates in blastocysts treated with blastocoelic micro-
suction prior to vitrification. The non-expanded
blastocyst survival rate improved significantly with micro-
Table 3: Studies showing different methods of blastocyst pre-vitrification interventions and their outcome parameters
Blastocoele Evacuation
Authors, year Species Method Intervention Sample 
size
Outcome parameter Intervention Control
Vanderzwalmen et al. 
2002[37]
Human Micro-needle puncture N = 75 Survival rate 70.6% 20.3%
Pregnancy rate 20.5% 4.5%
Implantation rate 18.4% 7.1%
Son et al. 2003[43] Human Micro-needle puncture N = 90 Survival rate 90.0% ---
Pregnancy rate 48.0% ---
Implantation rate 29.0% ---
Hiraoka et al. 2004[44] Human Micropipetting N = 48 Survival rate 98.0% ---
Pregnancy rate 50.0% ---
Implantation rate 33.0% ---
Chen et al. 2005[42] Mice Microsuction N = 108 Survival rate 92.0% 80.0%
Mukaida et al. 
2006[41]
Human Microneedle puncture N = 462 Survival rate 97.2% 85.0%
Pregnancy rate 60.2% 34.1%
Implantation rate 46.5% ---
Mukaida et al. 
2006[41]
Human Laser pulse N = 40 Survival rate 97.5% 85.0%
Pregnancy rate 61.5% 34.1%
Implantation rate 48.6% ---
Kader et al. 2009[45] Mice Microsuction N = 22 DNA integrity index 90.1% 77.6%
Zonal Hatching
Author, year Species Method Intervention Sample 
size
Outcome parameter Intervention Control
Zech et al. 2005[40] Human Spontaneous and
Assisted (Mechanically)
N = 38 Survival rate 82% 64%
Pregnancy rate 35% 21%
Implantation rate 26% 12%
Kader et al. 2009[45] Mice Assisted 
(Acidified Tyrod's)
N = 16 DNA integrity index 94.6% 84.4%
Spontaneous N = 12 DNA integrity index 88.5% 77.6%Reproductive Biology and Endocrinology 2009, 7:99 http://www.rbej.com/content/7/1/99
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suction, and the survival rate for the expanded blastocysts
improved from 59% to 89%. We have previously demon-
strated significant improvement in the DNA integrity
index by microsuction of mice blastocysts prior to vitrifi-
cation compared with blastocyst vitrification without any
pre-intervention [45]
Table 3 summarizes the results of studies assessing the
outcomes of pre-vitrification assisted shrinkage.
Improvement in media protocols
Since the inception of vitrification as a technique, many
different media protocols have been tested to achieve
proper intracellular cryoprotectant delivery.
Single versus multiple cryoprotectants
In the early 1990s, investigators often used single expo-
sure to a highly concentrated solution composed of one
cryoprotectant. In 1991, Li and Trounson [46] found that
the use of dimethyl sulfoxide (DMSO), 1,2-propanediol
and glycerol in combination yielded better post-thaw
blastocyst survival rate (61%) than when either cryopro-
tectant was used alone. With two cryoprotectants, the con-
centration of each can be lower than that needed when
either is used separately, thereby making the solution less
toxic to the blastocysts.
Macromolecules
Extracellular disaccharides and macromolecules, such as
sucrose and Ficoll are commonly added to vitrification
solutions. This helps draw water out of the blastocoele to
attain better dehydration and reduce osmotic shock. The
addition of macromolecules also means that the concen-
tration of cryoprotectants can be lowered [14,47].
Single versus multiple steps
A single exposure to a cryoprotectant subjects the blasto-
cyst to an increased risk of osmotic shock, particularly
when the concentration is extremely high. Depending on
the duration of exposure, a single immersion may not
allow enough time for adequate cryoprotectant permea-
tion into the blastocoele. Survival rates after vitrification
improved with the evolution of two-step protocols. In the
two-step protocols, the blastocyst is allowed to equilibrate
for a few minutes at a lower cryoprotectant concentration
before a short exposure to the vitrification solution at a
higher concentration [14]. This enables the cryoprotect-
ants to more gradually and effectively permeate the blast-
ocysts while reducing the risk of osmotic shock and
toxicity. Investigators comparing one-step and two-step
protocols demonstrated significantly improved survival
rates ranging from 70% to 90% with the two-step method
[48-50].
Survival and hatching rates tend to decline when the con-
centrations of cryoprotectants become too high, especially
in the blastocyst stage, which requires a delicate balance
between high cryoprotectant delivery and ensuing cellular
toxicity. One of the most commonly used protocols con-
sists of an equilibrium solution of 7.5% ethylene glycol
(EG) and 7.5% DMSO mixture, followed by a vitrification
solution of 15% EG and 15% DMSO [13,41,44]. Proto-
cols that use combinations of cryoprotectants at very high
concentrations tend to have lower survival and hatching
rates [51,52].
Media volume
Using a small volume of media expedites heat transfer by
minimizing the freezing or warming propagation time.
Theoretically, a very small drop (~ 5 nL) of pure water
should vitrify, if cooled very rapidly [53]. The freezing rate
is slower when larger drops are used. In the presence of
impurities or a temperature above the glass transition
temperature (-140°C), ice nucleation is likely to occur. Ice
nucleation is a critical event and must be avoided since a
single nucleation event in the liquid material before vitri-
fication is reached will trigger crystallization of the speci-
men [54].
In order to achieve the maximal freezing rates, current vit-
rification loading devices hold a minimal volume of solu-
tion such as the EM grid, cryoloop™, cryotip™, and Cryo-
leaf™ high security straws.
Currently most acceptable target in designing vitrification
loading devices for oocytes or embryos is to use a small
volume (<1 μl) of high-concentration cryoprotectant (~
30%), and very rapid freezing rates of 15,000 to
30,000°C/min [55].
Freezing rate
A high freezing rate is crucial to achieving proper vitrifica-
tion and survival. This can be achieved via direct contact
between the sample and liquid nitrogen or indirect con-
tact if the sample is contained in a closed carrier.
Direct contact vitrification
In this method, a high freezing rate is achieved by avoid-
ing any delay that may be caused by the carrier walls. This
method was considered the gold standard for vitrification
until concerns about liquid nitrogen contamination led
researchers to develop closed systems [56,57]. The EM
grid is an example of an old open method.
Closed system vitrification
In a closed system, the specimen is not allowed to directly
come in contact with the liquid nitrogen. Therefore, a car-
rier is required to deliver the maximum heat transfer rate
to the contained specimen. Closed containers try toReproductive Biology and Endocrinology 2009, 7:99 http://www.rbej.com/content/7/1/99
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achieve this minimal impedance of heat transfer by design
(being ultrathin, containing microvolumes) and by mate-
rial selection. The most recent developments in the closed
systems are the CryoTip™ and Cryo-leaf™ the high security
straws (HSS).
Cut standard straws hold blastocysts in a 0.75 μl chamber
with a freezing rate of 15,000°C/min if open and 600°C/
min if closed. Isachenko et al [58] did not report any dif-
ference in the survival rate of blastocysts vitrified in the
open or closed system. This demonstrates that vitrification
can occur at a lower-than-expected freezing rate.
An alternative way to increase the freezing rate is to
decrease the temperature of the liquid nitrogen. This
increases the freezing through two mechanisms: (1) the
wider difference in temperature leads to more rapid trans-
fer and (2) it minimizes the chances of insulating gas bub-
ble formation. Two mechanisms have been described to
decrease the nitrogen temperature:
1. Vacuum application over the liquid nitrogen would
decrease the liquid nitrogen temperature to range
between -200°C to -210°C as a result of elimination
of heating and evaporation at the liquid/gas interface
[54,59-61].
2. Nitrogen slush with a temperature of -210°C is less
likely to evaporate on contact with the specimen com-
pared to liquid nitrogen, [62].
Warming rate
Proper warming is as important as rapid freezing to
achieve proper vitrification-devitrification [54]. This is
usually done with the immediate transfer of the sample to
a pre-warmed (37°C) environment while making sure
this temperature is immediately available to the sample.
This can be done in open methods by mixing the sample
in pre-warmed media or in closed methods by plunging
the sample in its loading device into a warm water bath.
The heating rate will be controlled by the same factors that
control the freezing rate.
Because dilution of the cryoprotectants and re-expansion
of the blastocoele occur during the warming process, it is
necessary to perform the process using a series of media
with gradually decreasing osmotic pressure in an effort to
reduce osmotic shock [21]. One commonly used warming
protocol uses three steps, beginning with 0.3 mol/L
sucrose in base medium, followed by transfer to 0.2 mol/
L sucrose in base medium, and finally to a solution con-
taining only base medium [41].
Operator factors
The vitrification outcome is highly operator dependent,
and it requires a totally different skill set than is needed
with slow freezing. The embryologist should be rapidly
handling the embryos in micro-volumes of highly viscous
media. Also, because there are a variety of loading devices
available, specific training on the use and storage of a cer-
tain device and standardization of quality control proce-
dures is mandatory. The embryologist should be well
oriented to the different critical procedural details that can
affect the vitrification outcome. Those details can be sum-
marized as follows:
1. The types and concentrations of cryoprotectants
used and their toxicity threshold
2. The temperature of the vitrification solution at
exposure
3. Avoidance of media mixing in multi-step protocols
4. The duration of exposure to the final cryoprotect-
ants before plunging into LN2
5. The rapid loading
6. Sealing in a closed system
7. System validation (loading, sealing, storage)
Future perspectives
Researchers are currently studying different methods to
improve vitrification outcome by manipulating the essen-
tial factors (Cryoprotectants concentrations, constituents,
freezing rate, warming). The vitrification of embryos has
shown to be successful at low cryoprotectant concentra-
tion and increased rate of freezing. [63].
Simultaneously, non traditional tools such as the effect of
high hydrostatic pressure (HHP) in the pre-treatment of
oocytes and embryos, including blastocysts to improve
vitrification outcomes is also under investigation.
Research has shown that HHP leads to the production of
heat shock proteins in mammalian cells [64], which could
potentially provide enough cellular protection to main-
tain homeostasis and even improve cryoprotection [65].
The types and amount of such proteins synthesized in the
stressed cells depend on the intensity and type of the heat
shock as well as on the stressed cell type and state.
Recent studies have reported promising results when
applying HHP prior to vitrification of murine blastocysts,
mature porcine oocytes and boar semen [39,66-69]. For
example, applying hydrostatic pressure of 60 MegaPascals
(MPa) for 30 minutes then allowing four to five minutesReproductive Biology and Endocrinology 2009, 7:99 http://www.rbej.com/content/7/1/99
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before vitrification significantly improved the survival
and hatching rates of vitrified murine blastocysts [68].
The pressure level, pressure duration, temperature at time
of pressurizing, and recovery time before vitrification are
important parameters that need to be properly identified
for oocytes, embryos, and blastocysts of different species
[69]. However, further studies would be required to fully
understand and control this phenomenon as well as to
standardize its use. The use of high hydrostatic pressure
before vitrification is still under investigation.
Conclusion
Vitrification of blastocysts can be successfully carried out
using many loading devices. It could eventually replace
slow freezing of blastocysts as suggested by various reports
in the literature[70,71] Though effect on perinatal out-
come has not been fully investigated due to the novelty of
the technique in clinical practice, however, the available
data supports its potential safety. Other than the patient
clinical parameters, the clinical success of transferring vit-
rified blastocysts would rely on a multitude of factors. The
selection of a good quality embryo on preferably day 5
post fertilization is the 1st step. The selection of blastocysts
that show earlier re-expansion post-thaw for transfer
could improve the outcome from transferring vitrified
blastocysts. The assisted hatching and induction of blast-
ocoele collapse prior to vitrification have also shown to
improve the blastocyst vitrification outcome. Current
media protocols and loading devices are capable of
achieving proper vitrification attaining high level of vis-
cosity and dehydration of the blastocysts and delivering
high freezing and warming rates. Still further develop-
ments in vitrification media and devices are possible.
Finally, the embryologist training would have a major
bearing on the vitrification outcome.
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